Inventor · disambiguated record
John Crowley
Also filed as: CROWLEY JOHN · CROWLEY JOHN A
7 granted patents·7 pending applications·159 citations·filing 1980–2023
86Inventor score
Top patents by PatentIndex Score
14 records- 0192US9404100B2High concentration alpha-glucosidase compositions for the treatment of Pompe diseaseAMICUS THERAPEUTICS INC·Filed 2013·Granted Aug 2, 2016·16 cites·20 claims
- 0292US9303249B2High concentration α-glucosidase compositions for the treatment of Pompe diseaseAMICUS THERAPEUTICS INC·Filed 2013·Granted Apr 5, 2016·15 cites·18 claims
- 0389US4299568AOrthodontic applianceCROWLEY JOHN A·Filed 1980·Granted Nov 10, 1981·120 cites·18 claims
- 0487US10512677B2High concentration alpha-glucosidase compositions for the treatment of pompe diseaseAMICUS THERAPEUTICS INC·Filed 2018·Granted Dec 24, 2019·4 cites·15 claims
- 0587US10046033B2High concentration alpha-glucosidase compositions for the treatment of Pompe diseaseAMICUS THERAPEUTICS INC·Filed 2016·Granted Aug 14, 2018·4 cites·20 claims
- 0682US2023348532A1Manufacturing process for high titer antibodyREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0782US2023331776A1Manufacturing process for high titer antibodyREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0882US2023332084A1Bioreactor for antibody productionREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 0982US2023287043A1Cell culture methods for antibody productionREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1082US2023332201A1Cell culture methods for antibody productionREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1182US2024010737A1Manufacturing process for high titer antibodyREGENERON PHARMA·Filed 2023·Application pending·0 cites
- 1281US12419937B2High concentration alpha-glucosidase compositions for the treatment of Pompe diseaseAMICUS THERAPEUTICS INC·Filed 2022·Granted Sep 23, 2025·0 cites·18 claims
- 1371US11278599B2High concentration alpha-glucosidase compositions for the treatment of Pompe diseaseAMICUS THERAPEUTICS INC·Filed 2019·Granted Mar 22, 2022·0 cites·20 claims
- 1463US2023090912A1Methods of controlling antibody heterogeneityREGENERON PHARMA·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Crowley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →